78 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. |
Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS |
BMC medical genomics. 2015 Aug 22. doi: 10.1186/s12920-015-0129-6. pii: 10.1186/s12920-015-0129-6. pmc: PMC4546262 |
PMID: 26297356 |
Interleukin-10 inhibits autonomous myelopoiesis in patients with myelofibrosis. |
Geissler K, Jäger E, Öhler L, Gisslinger H, Jäger U, Lechner K |
European journal of haematology. 2015 Jan 7. doi: 10.1111/ejh.12486 |
PMID: 25404526 |
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma. |
Gebhart J, Lechner K, Skrabs C, Sliwa T, Müldür E, Ludwig H, Nösslinger T, Vanura K, Stamatopoulos K, Simonitsch-Klupp I, Chott A, Quehenberger P, Mitterbauer-Hohendanner G, Pabinger I, Jäger U, Geissler K |
Thrombosis research. 2014 Aug 29. pii: S0049-3848(14)00457-5. doi: 10.1016/j.thromres.2014.08.021 |
PMID: 25201005 |
Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. |
Pleyer L, Germing U, Sperr WR, Linkesch W, Burgstaller S, Stauder R, Girschikofsky M, Schreder M, Pfeilstocker M, Lang A, Sliwa T, Geissler D, Schlick K, Placher-Sorko G, Theiler G, Thaler J, Mitrovic M, Neureiter D, Valent P, Greil R |
Leukemia research. 2014 Jan 18. pii: S0145-2126(14)00023-X. doi: 10.1016/j.leukres.2014.01.006 |
PMID: 24522248 |
High spontaneous granulocyte/macrophage-colony formation in patients with myelofibrosis. |
Hauer V, Jäger E, Sliwa T, Simanek R, Gisslinger H, Jäger U, Geissler K |
Leukemia research. 2013 Oct 14. pii: S0145-2126(13)00346-9. doi: 10.1016/j.leukres.2013.10.003 |
PMID: 24262286 |
Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study. |
Hassler MR, Pfeifer W, Knocke-Abulesz TH, Geissler K, Altorjai G, Dieckmann K, Marosi C |
Wiener klinische Wochenschrift. 2013 Aug 2. doi: 10.1007/s00508-013-0402-7 |
PMID: 23907204 |
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions. |
Valent P, Gastl G, Geissler K, Greil R, Hantschel O, Lang A, Linkesch W, Lion T, Petzer AL, Pittermann E, Pleyer L, Thaler J, Wolf D |
Critical reviews in oncology/hematology. 2011 Sep 7. pii: S1040-8428(11)00193-4. doi: 10.1016/j.critrevonc.2011.08.002 |
PMID: 21903413 |
Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes. |
Wimazal F, Germing U, Kundi M, Noesslinger T, Blum S, Geissler P, Baumgartner C, Pfeilstoecker M, Valent P, Sperr WR |
Cancer. 2010 May 4. doi: 10.1002/cncr.25036 |
PMID: 20209617 |
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform. |
Valent P, Lion T, Wolf D, Sillaber C, Agis H, Petzer A, Lang A, Kalhs P, Geissler D, Greil R, Linkesch W, Burgstaller S, Thaler J, Gastl G |
Wiener klinische Wochenschrift. 2008 Dec 31. doi: 10.1007/s00508-008-1100-8 |
PMID: 19116712 |
Mixed-lineage eosinophil/basophil crisis in MDS: a rare form of progression. |
Wimazal F, Baumgartner C, Sonneck K, Zauner C, Geissler P, Schur S, Samorapoompichit P, Müllauer L, Födinger M, Agis H, Sperr WR, Valent P |
European journal of clinical investigation. 2008 Apr 24. pii: ECI1950. doi: 10.1111/j.1365-2362.2008.01950.x |
PMID: 18445043 |
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571). |
Agis H, Sperr WR, Herndlhofer S, Semper H, Pirc-Danoewinata H, Haas OA, Mannhalter C, Esterbauer H, Geissler K, Sillaber C, Jäger U, Valent P |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2007 Sep 5. pii: mdm343. doi: 10.1093/annonc/mdm343 |
PMID: 17804468 |
Cortical lateralization of bilateral symmetric chin movements and clinical relevance in tumor patients--a high field BOLD-FMRI study. |
Foki T, Geissler A, Gartus A, Pahs G, Deecke L, Beisteiner R |
NeuroImage. 2007 May 22. pii: S1053-8119(07)00394-1. doi: 10.1016/j.neuroimage.2007.02.059 |
PMID: 17560128 |
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase. |
Sonneck K, Mannhalter C, Krauth MT, Sperr WR, Schwarzinger I, Fonatsch C, Haas O, Geissler K, Valent P |
European journal of haematology. 2005 Jun 10. pii: EJH423. doi: 10.1111/j.1600-0609.2005.00423.x |
PMID: 15946315 |
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience. |
Böhm A, Piribauer M, Wimazal F, Geissler K, Gisslinger H, Knöbl P, Jäger U, Fonatsch C, Kyrle PA, Valent P, Lechner K, Sperr WR |
Leukemia research. 2005 Jan 25. pii: S0145-2126(04)00381-9. doi: 10.1016/j.leukres.2004.10.009 |
PMID: 15863199 |
FMRI reveals functional cortex in a case of inconclusive Wada testing. |
Lanzenberger R, Wiest G, Geissler A, Barth M, Ringl H, Wöber C, Gartus A, Baumgartner C, Beisteiner R |
Clinical neurology and neurosurgery. 2005 Feb 14. pii: S0303-8467(04)00083-6. doi: 10.1016/j.clineuro.2004.06.006 |
PMID: 15708233 |
Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation. |
Agis H, Mannhalter C, Sperr WR, Keil F, Kalhs P, Pirc-Danoewinata H, Krauth MT, Haas OA, Geissler K, Lechner K, Valent P |
Leukemia & lymphoma. 2004 Sep 13. |
PMID: 15359647 |
Human leukaemic stem cells: a novel target of therapy. |
Sperr WR, Hauswirth AW, Florian S, Ohler L, Geissler K, Valent P |
European journal of clinical investigation. 2004 Aug 4. doi: 10.1111/j.0960-135X.2004.01368.x. pii: ECI1368 |
PMID: 15291804 |
A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). |
Sperr WR, Piribauer M, Wimazal F, Fonatsch C, Thalhammer-Scherrer R, Schwarzinger I, Geissler K, Knöbl P, Jäger U, Lechner K, Valent P |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Jun 25. doi: 10.1158/1078-0432.CCR-04-0185. pii: 10/12/3965 |
PMID: 15217926 |
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse. |
Weltermann A, Fonatsch C, Haas OA, Greinix HT, Kahls P, Mitterbauer G, Jäger U, Kainz B, Geissler K, Valent P, Sperr WR, Knöbl P, Schwarzinger I, Gleiss A, Lechner K |
Leukemia. 2004 Jan 22. doi: 10.1038/sj.leu.2403243. pii: 2403243 |
PMID: 14671635 |
Drug resistance factors in acute myeloid leukemia: a comparative analysis. |
Filipits M, Stranzl T, Pohl G, Heinzl H, Jäger U, Geissler K, Fonatsch C, Haas OA, Lechner K, Pirker R |
Leukemia. 2000 Feb 2. |
PMID: 10637479 |
78 Einträge | 1, 2, 3, 4 › » |
Seite 1 / 4
![]() |